{"version":"1.0","type":"link","title":"Long-term benefit from adjuvant tamoxifen therapy for ER+ HER2- breast cancer by PR positivity.","author_name":"Nordenskjöld AE 외","author_url":"https://prs-insight.online/author/Nordenskj%C3%B6ld%20AE","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/82036","thumbnail_width":1200,"thumbnail_height":630}